As per the launch, first-time users would be receiving two $5 vouchers that could be used within two weeks of signing-up. The Go-Jek ride-hailing smartphone application would be made available for both Android & iOS users. GO-JEK (Go-Jek), an Indonesian logistics & ride-hailing company, has …
The founder of Oracle Corporation, Larry Ellison, has reportedly purchased 3 million Tesla shares for USD 1 billion, the electric carmaker mentioned in a regulatory filing on January 8. As per trusted sources, the stake purchase makes Ellison the second-biggest individual investor of Tesla after …
SoftBank Group Corp, a Japanese multinational holding conglomerate, has reportedly announced that it will inject a further of $2 billion in WeWork this year, bringing its total investment in the workspace provider to over $10 billion. For the record, earlier in August 2018, WeWork received …
The merger will create a Franco-German champion that challenges Chinese designs in the rail industry. German conglomerate, Siemens AG and French rail company Alstom SA are reportedly pushing ahead with the sale of train-equipment assets in a bid to re-claim their rail merger amidst European …
Vanderbilt University Medical Center (VUMC) has recently announced that it has entered into a five-year partnership with GE Healthcare for enabling more precise and safer cancer immunotherapies. Apparently, various diagnostic tools would be developed for predicting the immunotherapy treatment’s efficacy as well as its adverse …
DNO previously required the support of 57.5% Faroe shareholders but now only requires 50%. DNO’s takeover attempts intensified after it lifted its stakes in Faroe. DNO ASA (DNO), a renowned Norwegian oil and gas operator, has reportedly announced that it now requires the support of …
The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …
The biotechnology company GeoVax Labs, Inc. has reportedly announced to have joined hands with the pharmaceutical firm Enesi Pharma to develop needle-free solid-dose vaccine formulations by using its unique Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform along with Enesi’s ImplaVax® device and formulation technology. …
